Loading organizations...
Key people at ING Corporate Investments.
ING Corporate Investments is the private equity arm of ING Group, based in Amsterdam, North Holland, Netherlands, focusing on private equity management and investments across diverse sectors. The entity actively engages in acquisitions and deals, aiming to generate returns through strategic equity investments and subsequent exits, having been involved in 11 transactions to date. Its portfolio development includes recent deal values such as the acquisition of healthcare provider Medicore for €50-100 million, executed in partnership with Extens, and the acquisition of Mosa for €59.20 million. Operating as a strategic investor, ING Corporate Investments targets companies for acquisition to build and manage a diversified portfolio, leveraging its expertise in private equity to identify and capitalize on growth opportunities. The organization was founded in 1997; founder names are not publicly known.
ING Corporate Investments has 1 tracked investment across 1 company. The latest tracked deal is $65.0M Other Equity in Agendia in May 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 31, 2012 | Agendia | $65.0M Other Equity | Debiopharm | Breedinvest, Korys, VAN Herk Ventures |
Key people at ING Corporate Investments.